Predict your next investment

Venture Capital
grainsvalley.com

See what CB Insights has to offer

Investments

52

Portfolio Exits

4

Funds

2

About Grains Valley Venture Capital

Grains Valley Venture Capital, fka Pangu Jinfu Capital, is a China-based venture capital firm with a focus on the Internet, life sciences, clean technology, artificial intelligence, and culture.

Grains Valley Venture Capital Headquarter Location

Beijing, Beijing,

China

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Grains Valley Venture Capital

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Grains Valley Venture Capital in 1 Expert Collection, including Pharma Startups.

P

Pharma Startups

5,090 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

Grains Valley Venture Capital Investments

52 Investments

Grains Valley Venture Capital has made 52 investments. Their latest investment was in Elixiron Immunotherapeutics as part of their Series A - II on August 8, 2021.

CBI Logo

Grains Valley Venture Capital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

8/16/2021

Series A - II

Elixiron Immunotherapeutics

$30.88M

Yes

3

7/20/2021

Seed VC

Xiaoha Huandian

Yes

4

7/9/2021

Series A - III

MEMECT

No

4

6/24/2021

Series D - II

Subscribe to see more

$99M

Subscribe to see more

10

4/16/2021

Series A

Subscribe to see more

$99M

Subscribe to see more

10

Date

8/16/2021

7/20/2021

7/9/2021

6/24/2021

4/16/2021

Round

Series A - II

Seed VC

Series A - III

Series D - II

Series A

Company

Elixiron Immunotherapeutics

Xiaoha Huandian

MEMECT

Subscribe to see more

Subscribe to see more

Amount

$30.88M

$99M

$99M

New?

Yes

Yes

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

3

4

4

10

10

Grains Valley Venture Capital Portfolio Exits

4 Portfolio Exits

Grains Valley Venture Capital has 4 portfolio exits. Their latest portfolio exit was Ascentage Pharma on October 28, 2019.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

10/28/2019

IPO

$991

4

00/00/0000

Subscribe to see more

Subscribe to see more

$991

Subscribe to see more

10

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

Date

10/28/2019

00/00/0000

00/00/0000

00/00/0000

Exit

IPO

Subscribe to see more

Subscribe to see more

Subscribe to see more

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$991

$991

Acquirer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

4

10

10

10

Grains Valley Venture Capital Fund History

2 Fund Histories

Grains Valley Venture Capital has 2 funds, including Tianjin Heyiguyu Equity Investment LP.

Closing Date

Fund

Fund Type

Status

Amount

Sources

7/31/2011

Tianjin Heyiguyu Equity Investment LP

Early-Stage Venture Capital

$30.92M

1

4/20/2011

Tianjin Heyueguyu Equity Investment LP

Subscribe to see more

$99M

10

Closing Date

7/31/2011

4/20/2011

Fund

Tianjin Heyiguyu Equity Investment LP

Tianjin Heyueguyu Equity Investment LP

Fund Type

Early-Stage Venture Capital

Subscribe to see more

Status

Amount

$30.92M

$99M

Sources

1

10

Grains Valley Venture Capital Team

1 Team Member

Grains Valley Venture Capital has 1 team member, including current Managing Partner, Haibin Liu.

Name

Work History

Title

Status

Haibin Liu

Managing Partner

Current

Name

Haibin Liu

Work History

Title

Managing Partner

Status

Current

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.